15-Carboethoxy-pentadecansaeure | 18017-66-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 15-Carboethoxy-pentadecansaeure
• 英文别名: hexadecanedioic acid monoethyl ester；Hexadecandisaeure-monoaethylester；16-Ethoxy-16-oxohexadecanoic acid
• CAS: 18017-66-8
• 化学式: C₁₈H₃₄O₄
• 分子量: 314.466
• InChiKey: ZWPJRKLZKQOMOV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6
• 重原子数：
  22
• 可旋转键数：
  17
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  15-Carboethoxy-pentadecansaeure 在 盐酸 、 氯化亚砜 、 氨 、 水 、 溴 、 苯 作用下， 生成 15,15'-thioureylene-di-pentadecanoic acid
  参考文献：
  名称：

  Amino Acids. V. 1,3-Di-(ι-carboxyalkyl)-thioureas and Their Chemistry

  摘要：

  DOI：

  10.1021/ja01539a058
• 作为产物：
  描述：

  diethyl hexadecanedioate 在 barium dihydroxide 、 乙醇 作用下， 生成 15-Carboethoxy-pentadecansaeure
  参考文献：
  名称：

  Below et al., 1958, # 4, p. 3,17

  摘要：

  DOI：

文献信息

• Studies on biologically active nucleosides and nucleotides. 5. Synthesis and antitumor activity of some 2,2'-anhydro-1-(3',5'-di-O-acyl-.beta.-D-arabinofuranosyl)cytosine salts and 2,2'-anhydro-1-(3'-O-acyl-.beta.-D-arabinofuranosyl)cytosine 5'-phosphates
  作者：Kazuhiko Kondo、Takeo Nagura、Yoshihisa Arai、Ichizo Inoue

  DOI：10.1021/jm00192a007

  日期：1979.6

  substituents on the ester side chains (4--16) have been synthesized. The synthesis of these diesters involved the reaction between cytidine and the corresponding acid anhydride or acid chloride in the presence of boron trifluoride etherate. Similar reaction of bis(cytidine 5'-)suberate (21) with pivaloyl chloride gave bis[2,2'-anhydro-1-(3'-O-pivaloyl-beta-D-arabinofuranosyl)cytosine 5'-]suberate dihydrochloride

  合成了在酯侧链（4--16）上带有官能取代基的2,2'-脱水-1-（β-D-阿拉伯呋喃糖基）胞嘧啶盐的一系列3'，5'-二酯。这些二酯的合成涉及胞苷和相应的酸酐或酰氯在三氟化硼醚化物的存在下的反应。双（胞苷5'-）硬脂酸酯（21）与新戊酰氯的类似反应，得到双[2,2'-脱水-1-（3'-O-新戊酰-β-D-阿拉伯呋喃糖基）胞嘧啶5'-]硬脂酸酯二盐酸盐（22）。该反应还可以扩展为由5'-胞苷酸一步合成2，2'-脱水-1-（β-D-阿拉伯呋喃糖基）胞嘧啶5'-磷酸（24）的3'-酯。已经检查了这些化合物在BDF1小鼠中对L1210白血病的抗肿瘤活性。腹膜内给药时，具有长链羧酸（4c，7c，12和24d）的二酯表现出高活性。口服给药时，化合物24d表现出中等活性。
• Location of hydroperoxide groups in monohydroperoxides formed by chlorophyll-photosensitised oxidation of unsaturated esters
  作者：D. Cobern、J. S. Hobbs、R. A. Lucas、D. J. Mackenzie

  DOI：10.1039/j39660001897

  日期：——

  Monohydroperoxides were isolated from chlorophyll-photosensitised oxidation of methyl oleate, methyl linoleate, methyl linolenate, and ethyl arachidonate. The positions of the hydroperoxide substituent were determined by two methods of analysis of the saturated hydroxy-esters formed by catalytic hydrogenation. Gas–liquid chromatographic analysis of degradation products and mass spectrometric analysis

  从油酸甲酯，亚油酸甲酯，亚油酸甲酯和花生四烯酸乙酯的叶绿素光敏氧化分离出单氢过氧化物。通过两种分析由催化氢化形成的饱和羟基酯的方法确定氢过氧化物取代基的位置。降解产物的气液色谱分析和相应的酮酸酯的质谱分析均证明氢过氧化物基团位于最初形成双键一部分的每个碳原子上。
• [EN] CARBOXYLATED 2'-AMINO-LNA NUCLEOTIDES AND OLIGONUCLEOTIDES COMPRISING THE SAME<br/>[FR] NUCLÉOTIDES 2'-AMINO-LNA CARBOXYLÉS ET OLIGONUCLÉOTIDES COMPRENANT CEUX-CI
  申请人：PANZNER STEFFEN

  公开号：WO2018033492A1

  公开（公告）日：2018-02-22

  The invention proves an oligonucleotide comprising one or more carboxylated 2'- amino-LNA nucleotide units. The invention also provides a method of transfecting cells with the oligonucleotide, a method of treating a human or animal by therapy using the oligonucleotide, and a pharmaceutical composition comprising the oligonucleotide.

  该发明证明了一种寡核苷酸，其中包含一个或多个羧化的2'-氨基-LNA核苷酸单元。该发明还提供了一种使用该寡核苷酸转染细胞的方法，一种使用该寡核苷酸进行治疗人类或动物的方法，以及包含该寡核苷酸的制药组合物。
• HUMAN INSULIN ANALOGUE AND ACYLATED DERIVATIVE THEREOF
  申请人：Shanghai Hengrui Pharmaceutical Co., Ltd.

  公开号：US20140329745A1

  公开（公告）日：2014-11-06

  The present invention provides a human insulin analogue, an acylated derivative thereof and a physiologically acceptable salt. The present invention further provides a preparation method for the insulin analogue and an application of the insulin analogue as a therapeutic agent, and particularly as a diabetes mellitus therapeutic agent.

  本发明提供了一种人胰岛素类似物、其酰化衍生物和生理上可接受的盐。本发明还提供了一种制备胰岛素类似物的方法以及胰岛素类似物作为治疗剂的应用，特别是作为糖尿病治疗剂的应用。
• Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes
  申请人：McDaniel C. Steven

  公开号：US20100210745A1

  公开（公告）日：2010-08-19

  Disclosed herein are polymeric materials such as a coating, a plastic, a laminate, a composite, an elastomer, an adhesive, or a sealant; a surface treatment such as a textile finish or a wax; a filler for such a polymeric material or a surface treatment that includes an enzyme such as an esterase (e.g., a lipolytic enzyme, a sulfuric ester hydrolase, an organophosphorus compound degradation enzyme), an enzyme (e.g., a lysozyme, a lytic transglycosylase) that degrades a cell wall and/or a cell membrane component, a biocidal or biostatic peotide, and/or a peptidase. Also disclosed herein are methods of altering a material's property such as service life, flexability, or rigidity, by incorporation of an enzyme into a material capable of being chemically crosslinked by the activity of a lipolytic enzyme, a hydrolase, and/or a urease.

  本文公开了一些聚合材料，如涂层、塑料、层压板、复合材料、弹性体、粘合剂或密封剂；一种表面处理，如纺织品涂层或蜡；一种填料，用于这样的聚合材料或表面处理，其中包括一种酶，如酯酶（例如，脂肪水解酶，硫酸酯水解酶，有机磷化合物降解酶），降解细胞壁和/或细胞膜成分的酶（例如，溶菌酶，裂解转糖基酶），生物杀菌或生物静态肽，以及/或肽酶。本文还公开了通过将酶纳入可通过脂肪水解酶、水解酶和/或脲酶的活性交联材料中来改变材料性能，如使用寿命、柔韧性或刚度的方法。